0000899243-20-024894.txt : 20200911 0000899243-20-024894.hdr.sgml : 20200911 20200911160526 ACCESSION NUMBER: 0000899243-20-024894 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200910 FILED AS OF DATE: 20200911 DATE AS OF CHANGE: 20200911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Turtle Cameron CENTRAL INDEX KEY: 0001758363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38533 FILM NUMBER: 201170969 MAIL ADDRESS: STREET 1: C/O EIDOS THERAPEUTICS, INC. STREET 2: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eidos Therapeutics, Inc. CENTRAL INDEX KEY: 0001731831 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463733671 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-391-9740 MAIL ADDRESS: STREET 1: 101 MONTGOMERY STREET, SUITE 2550 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-10 0 0001731831 Eidos Therapeutics, Inc. EIDX 0001758363 Turtle Cameron C/O EIDOS THERAPEUTICS, INC. 101 MONTGOMERY STREET, SUITE 2000 SAN FRANCISCO CA 94104 0 1 0 0 Chief Business Officer Common Stock 2020-09-10 4 M 0 2500 17.00 A 73031 D Common Stock 2020-09-10 4 S 0 2500 47.00 D 70531 D Stock Option (Right to Buy) 17.00 2020-09-10 4 M 0 2500 0.00 D 2028-06-20 Common Stock 2500 16420 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2019. The shares subject to this option vest and become exercisable in 48 equal monthly installments after June 18, 2018, subject to the Reporting Person's continuous service to the Issuer through each such vesting date. /s/ Franco Valle, as Attorney-in-Fact 2020-09-11